Bioporto AS (OCSE:BIOPOR) Net Change in Cash : kr-12.44 Mil (TTM As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Bioporto AS Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Bioporto AS's Net Change in Cash for the three months ended in Mar. 2025 was kr-26.82 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was kr-12.44 Mil.

Bioporto AS Net Change in Cash Historical Data

The historical data trend for Bioporto AS's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioporto AS Net Change in Cash Chart

Bioporto AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

89.82

-62.42

36.27

-15.39

-6.74

Bioporto AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-21.12	58.63	-27.57	-16.68	-26.82

Bioporto AS Net Change in Cash Calculation

Bioporto AS's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-83.583	+	1.187	+	75.466	+	0.192
	=	-6.74

Bioporto AS's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -24.106 + -1.832 + -0.965 + 0.081

= -26.82

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-12.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioporto AS Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Bioporto AS's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioporto AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioporto AS (OCSE:BIOPOR) » Definitions » Net Change in Cash

Comparable Companies

TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH XPAR:BIM ILMN ICLR RVTY XPAR:ERF QGEN MEDP EXAS

Traded in Other Exchanges

2P4:Germany

Address

Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900

Website

https://www.bioporto.com

Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.

Bioporto AS Headlines

No Headlines